NCT03532685View on ClinicalTrials.gov

Clinical, Inflammatory and Functional Evaluation of a Population of Severe and Obese Asthmatics: Follow up

NAUnknownINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 31, 2018

Primary Completion Date

May 31, 2018

Study Completion Date

February 28, 2019

Conditions
Severe AsthmaObesity
Interventions
PROCEDURE

Bariatric

withdrawing a part of the stomach and may or may not be combined with bowel deviation

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Sao Paulo General Hospital

OTHER